Cost-Effectiveness Analysis of Bendamustin-Rituximab Compared to Chop-Rituximab in the Treatment of Indolent Follicular Non-Hodgkin Lymhoma in the Czech Republic
Abstract
Authors
T. Mlcoch J. Klimes K. Kruntoradova M. Mandelikova T. Dolezal